Targeting B-Cell Neoplasia With T-Cell Receptors Recognizing a CD20-derived Peptide on Patient-Specific HLA
OncoImmunology - United States
doi 10.1080/2162402x.2016.1138199
Full Text
Open PDFAbstract
Available in full text
Date
February 18, 2016
Authors
Publisher
Informa UK Limited